Stocks and Investing Stocks and Investing
Tue, January 18, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Matthew Harrison Maintained (ARGX) at Hold with Decreased Target to $339 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Ebrahim Poonawala Initiated (ASB) at Sell and Held Target at $23 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Mitch Kummetz Initiated (ZUMZ) at Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Keith Weiss Upgraded (ZS) to Buy and Held Target at $325 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Robert Mollins Downgraded (ABNB) to Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Steve Scala Maintained (ABBV) at Buy with Increased Target to $150 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Christopher Raymond Reiterated (ABBV) at Buy and Held Target at $160 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Sidney Ho Maintained (AAPL) at Strong Buy with Increased Target to $200 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Steven Zaccone Maintained (BBY) at Strong Sell with Decreased Target to $90 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Simeon Gutman Maintained (BBY) at Hold with Decreased Target to $110 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Michael Lewis Downgraded (BDN) to Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Rupert Merer Upgraded (BEP) to Buy on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $360 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Andrew Fein Maintained (BIIB) at Strong Buy with Decreased Target to $270 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $360 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Chris Cooley Downgraded (ALC) to Hold and Decreased Target to $86 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Mitch Kummetz Initiated (UAA) at Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Simeon Siegel Upgraded (UAA) to Buy and Increased Target to $25 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Sheila Kahyaoglu Maintained (TXT) at Strong Buy and Held Target at $90 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Mitch Kummetz Initiated (WWW) at Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
George Choi Maintained (WYNN) at Hold with Increased Target to $95 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Deane Dray Maintained (XYL) at Buy and Held Target at $134 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Anthony Paolone Maintained (UDR) at Buy with Increased Target to $63 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Anthony Powell Maintained (UDR) at Buy and Held Target at $63 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Kevin Fischbeck Maintained (UNH) at Strong Buy and Held Target at $574 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Clarke Jeffries Initiated (VTEX) at Buy and Held Target at $13 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Diego Aragao Upgraded (VTEX) to Strong Buy and Decreased Target to $16 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Mitch Kummetz Initiated (VFC) at Hold on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Tyler Broda Upgraded (VALE) to Hold and Increased Target to $17 on, Jan 18th, 2022
[ Tue, Jan 18th 2022 ] - WOPRAI
Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $34 on, Jan 18th, 2022

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $34 on, Jan 18th, 2022


Published on 2024-10-27 19:18:01 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Decreased Target from $50 to $34 on, Jan 18th, 2022.

Raghuram, nor any peers, have made any analyst calls on URGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources